The Conversation (0)
TSO3 announced the use of the company’s medical technology by an undisclosed hospital in Canada.
TSO3 (TSX:TOS) announced the use of the company’s medical technology by an undisclosed hospital in Canada.
As quoted in the press release:
Additionally, the Company has successfully completed both a Quality System compliance inspection by US regulators and four weeks of comprehensive sales and marketing training with personnel from its exclusive distribution partner, the Getinge Group.
The Company announced that the second largest hospital in Canada has completed the installation of multiple STERIZONE® VP4 Sterilizers and is now using these sterilizers to terminally process duodenoscopes used on patients undergoing endoscopic retrograde cholangio-pancreatography (ERCP) procedures.
Click here to read the full press release.
Source: www.newswire.ca
